AiMC/AiTC syndicate backs digital health specialist LiveSmart with £700,000

LiveSmart, a preventive health solution, has closed a £700,000 investment round including private investors from Angels in MedCity (AiMC) and Angels in the City (AiTC) and the London Co-Investment Fund (LCIF).

LiveSmart is developing a digital health improvement platform that is effective at driving behaviour change. The LiveSmart platform has already led to a significant number of clients taking positive health actions which have resulted in improved health scores.

The LiveSmart service is broken down into 3 key parts:

• Collection – Pathology is collected via using a finger prick home test kit, through one of 50 clinics or using LiveSmart’s home visit service which covers the UK and Ireland. Data is also self-reported by the user and pulled in from all major wearable devices. The company has European reach with new pathology labs in France under contract.
• Analysis – Results are then analysed by a GP together with a dietician before personal actions are given to customers. Results can be viewed online or via one of LiveSmart’s mobile apps.
• Health Coaching – Customers then have the option to move onto LiveSmart’s telephone-coaching programme.

The company’s strategy for growth is through B2B and channel partnerships. The business pipeline is growing at a fast rate month on month. LiveSmart currently has strong engagement in the occupational health, intermediary and insurance sector.

This new round of funding will enable the company to resource new trial studies, continue to build out its technology and marketing functions and to execute its sales strategy.


Alex Heaton, Founder and CEO, commented, “Clients are buying our products because we have a market leading proposition that engages users and delivers lasting health outcomes”

Sarah Haywood, MedCity’s CEO, commented, “We are delighted to see another company access the substantial funding they need to get to the next stage of growth. Digital Health companies like LiveSmart are revolutionising healthcare and are especially valuable in preventing and treating metabolic and cardiovascular diseases which is also why LiveSmart is currently part of the DigitalHealth.London accelerator programme.”

Anthony Clarke, LBA CEO, commented, “the LiveSmart team has developed an innovative method for people to better monitor their health and wellness and be able to take positive actions to improve these. Already the product is being actively used by a number of blue chip clients and this new round of funding means that the company is poised to accelerate its growth.“

For more information about LiveSmart: